Table 3. Clinical response according to LMR-week 6 for 121 patients.
Response | Number (N=121, %) | Low LMR-week 6 (N=66, 54.5%) | High LMR-week 6 (N=55, 45.5%) |
---|---|---|---|
CR | 8 (6.6) | 1 (1.5) | 7 (12.7) |
PR | 15 (12.4) | 4 (6.1) | 11 (20.0) |
SD | 34 (28.1) | 22 (33.3) | 12 (21.8) |
PD | 64 (52.9) | 39 (59.1) | 25 (45.5) |
N, number; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; LMR-week 6, lymphocyte-to-monocyte ratio 6 weeks after the start of PD-1 inhibitors.